Rashi Peripherals Limited Submits SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 14 Apr 2026, 09:05 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Rashi Peripherals Limited submitted its Q4FY26 confirmation certificate under SEBI Regulation 74(5) on April 14, 2026, covering the quarter ended March 31, 2026. The certificate from RTA MUFG Intime India Private Limited confirmed that all company shares remain in demat form with no rematerialisation requests received during the quarter. The filing demonstrates the company's ongoing compliance with SEBI depositories regulations and corporate governance requirements.

powered bylight_fuzz_icon
37726556

*this image is generated using AI for illustrative purposes only.

Rashi Peripherals Limited has submitted its quarterly compliance certificate to stock exchanges, confirming adherence to SEBI regulations regarding share dematerialization for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company filed the confirmation certificate on April 14, 2026, with both BSE Limited and the National Stock Exchange of India Limited. The submission was made pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Parameter: Details
Filing Date: April 14, 2026
Certificate Date: April 2, 2026
Quarter Covered: Q4FY26 (ended March 31, 2026)
Regulation: SEBI Regulation 74(5)

RTA Confirmation Details

MUFG Intime India Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate dated April 2, 2026. The RTA provided specific confirmation regarding the applicability of SEBI regulations to the company's shareholding structure.

Key Compliance Points

The certificate highlighted the following compliance aspects for Q4FY26:

  • Entire shareholding remains in dematerialized form
  • No rematerialisation requests received from shareholders during the quarter
  • Regulation 74(5) deemed not applicable due to complete demat holding structure

Corporate Governance Framework

The submission was signed by Arvind Bajoria, Company Secretary and Compliance Officer of Rashi Peripherals Limited. MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, continues to serve as the company's RTA with its registered address at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai.

Entity: Role
Arvind Bajoria: Company Secretary and Compliance Officer
MUFG Intime India Pvt Ltd: Registrar and Share Transfer Agent
Ashok Shetty: Sr. Vice President – Corporate Registry (RTA)

This quarterly compliance filing demonstrates the company's commitment to maintaining regulatory adherence and transparent corporate governance practices as mandated by SEBI regulations.

Historical Stock Returns for Rashi Peripherals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.90%+21.76%+33.46%+37.02%+52.15%+42.29%

Will Rashi Peripherals maintain its 100% dematerialized shareholding structure as the company scales and attracts new investor categories?

How might SEBI's evolving digital governance requirements impact Rashi Peripherals' compliance costs and operational processes in FY27?

Could the company's complete demat structure position it favorably for potential inclusion in ESG-focused investment indices or funds?

Rashi Peripherals Issues Postal Ballot Notice for Director Appointments with E-Voting Period from March 26-April 24, 2026

3 min read     Updated on 26 Mar 2026, 10:00 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Rashi Peripherals Limited has issued a postal ballot notice seeking shareholder approval for appointing Rajesh Goenka as Whole-Time Director and CEO with maximum annual remuneration of ₹14.00 crore, and Dr. Indumati Gopinathan as Independent Director. The company published newspaper advertisements on March 26, 2026, in Financial Express and Navshakti newspapers as per SEBI regulations.

powered bylight_fuzz_icon
36014650

*this image is generated using AI for illustrative purposes only.

Rashi Peripherals Limited has issued a comprehensive postal ballot notice dated February 3, 2026, seeking shareholder consent for the appointment of two directors through a special resolution process. The company has engaged MUFG Intime India Private Limited as the Registrar and Share Transfer Agent to facilitate the e-voting process for eligible shareholders.

E-Voting Schedule and Process

The remote e-voting period has been scheduled to provide shareholders adequate time for participation in the decision-making process. Mrs. Ragini Chokshi (FCS 2390, CP No. 1436), a Practicing Company Secretary from Mumbai, has been appointed as the Scrutinizer to ensure fair and transparent conduct of the postal ballot process.

Parameter: Details
Voting Commencement: Thursday, March 26, 2026 at 09:00 A.M. (IST)
Voting Conclusion: Friday, April 24, 2026 at 05:00 P.M. (IST)
Cut-off Date: Friday, March 20, 2026
Scrutinizer: Mrs. Ragini Chokshi (FCS 2390, CP No. 1436)
RTA: MUFG Intime India Private Limited

Proposed Director Appointments

The postal ballot notice encompasses two special resolutions for director appointments, both requiring shareholder approval through the e-voting mechanism.

Appointment of Mr. Rajesh Goenka as Whole-Time Director and CEO

Mr. Rajesh Goenka (DIN: 10985108) has been proposed for appointment as Whole-Time Director and Chief Executive Officer for a five-year term. The Board of Directors, based on the Nomination and Remuneration Committee's recommendation, approved his appointment as Additional Director on February 3, 2026. Mr. Goenka brings over 25 years of extensive experience in sales and marketing, holding a Bachelor's degree in Chemical Engineering from Pune University. He has been associated with the company since 2008 and was previously designated as CEO on September 23, 2022.

Remuneration Component: Amount
Basic Salary: ₹4,83,000 per month
House Rent Allowance: ₹2,41,500 per month
Special Allowance: ₹21,99,115 per month
Provident Fund: 12% of Basic Salary
Gratuity: ₹2,78,646 per annum
NPS Contribution: ₹50,000 per annum
Maximum Annual Remuneration: Up to ₹14.00 crore
Term Duration: February 3, 2026 to February 2, 2031

Appointment of Dr. Indumati Gopinathan as Independent Director

Dr. Indumati Gopinathan (DIN: 06779331) has been proposed for appointment as an Independent Director. She is an experienced pathologist with MBBS and MD degrees from Seth G.S. Medical College, Mumbai, and currently serves as an Independent Director at Thyrocare Technologies Limited. Her expertise spans pathology department leadership, ocular pathology, uropathology, and healthcare governance.

Appointment Details: Information
Position: Independent Director
Tenure Start: February 3, 2026
Tenure End: Conclusion of 38th AGM in 2027
Age: 69 Years
Current Directorships: Thyrocare Technologies Limited
Shareholding: Nil

Newspaper Advertisement Publication

The company published newspaper advertisements regarding the postal ballot notice on March 26, 2026, in compliance with Regulation 30 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The advertisements were published in Financial Express (English Language) and Navshakti (Marathi Language). The announcement is also available on the company's website at www.rptechindia.com/investor .

Publication Details: Information
English Newspaper: Financial Express
Regional Newspaper: Navshakti (Marathi)
Publication Date: March 26, 2026
Website Link: www.rptechindia.com/investor

Shareholder Eligibility and Compliance

The postal ballot notice is being sent electronically to shareholders whose email addresses are registered with the company or depositories and whose names appear in the Register of Members as on the cut-off date of Friday, March 20, 2026. The voting rights will be proportionate to shareholders' paid-up equity share capital as on the cut-off date.

The company has ensured compliance with relevant regulations including Section 110 of the Companies Act, 2013, SEBI Listing Regulations, and various MCA circulars. Results will be uploaded on stock exchanges within two working days from the conclusion of the postal ballot and will be available on the company's website and MUFG Intime's platform.

Key Compliance and Documentation

Both proposed directors have submitted all required declarations and consents as mandated under the Companies Act, 2013 and SEBI regulations. The company has received notices under Section 160 of the Companies Act, 2013 from members proposing their candidatures. All necessary forms including DIR-2, DIR-8, and declarations regarding non-disqualification have been properly filed and verified.

Historical Stock Returns for Rashi Peripherals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.90%+21.76%+33.46%+37.02%+52.15%+42.29%

How might the appointment of a new CEO with 25 years of sales and marketing experience impact Rashi Peripherals' market expansion strategy and revenue growth trajectory?

What strategic initiatives could Dr. Indumati Gopinathan's healthcare governance expertise bring to Rashi Peripherals' board, particularly given her background in pathology and medical technology?

Will the ₹14 crore maximum annual remuneration package for the CEO signal increased investor confidence or raise concerns about executive compensation relative to company performance?

More News on Rashi Peripherals

1 Year Returns:+52.15%